CYNTHIA ADAME: Open Payments
NPI 1730624099 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,369 in 44 payments from 20 companies in 2025. Trend: 2023 $1,923 · 2024 $2,393 · 2025 $2,369
Food & beverage: $2,252Education: $117
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $325 |
| PFIZER INC. | 5 | $269 |
| E.R. Squibb & Sons, L.L.C. | 3 | $230 |
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| Incyte Corporation | 4 | $163 |
| Merck Sharp & Dohme LLC | 2 | $140 |
| Daiichi Sankyo Inc. | 1 | $133 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Geron Corporation | 1 | $123 |
| PharmaEssentia USA Corporation | 1 | $102 |
Products named: OPDIVO, IMFINZI, KEYTRUDA, Monjuvi, JEMPERLI, RYTELO, LORBRENA, RYBREVANT.
Industry payments across TX — which companies pay providers there.
